Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts.

Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. J Surg Oncol. 1985 Dec; 30(4):215-20.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.